Table of Contents 1 Hepatic Encephalopathy Drug Market Overview 1.1 Hepatic Encephalopathy Drug Product Overview 1.2 Hepatic Encephalopathy Drug Market Segment by Type 1.2.1 RBX-2660 1.2.2 KLS-13019 1.2.3 GR-3027 1.2.4 SYNB-1020 1.2.5 Others 1.3 Global Hepatic Encephalopathy Drug Market Size by Type 1.3.1 Global Hepatic Encephalopathy Drug Sales and Growth by Type 1.3.2 Global Hepatic Encephalopathy Drug Sales and Market Share by Type (2014-2019) 1.3.3 Global Hepatic Encephalopathy Drug Revenue and Market Share by Type (2014-2019) 1.3.4 Global Hepatic Encephalopathy Drug Price by Type (2014-2019) 2 Global Hepatic Encephalopathy Drug Market Competition by Company 2.1 Global Hepatic Encephalopathy Drug Sales and Market Share by Company (2014-2019) 2.2 Global Hepatic Encephalopathy Drug Revenue and Share by Company (2014-2019) 2.3 Global Hepatic Encephalopathy Drug Price by Company (2014-2019) 2.4 Global Top Players Hepatic Encephalopathy Drug Manufacturing Base Distribution, Sales Area, Product Types 2.5 Hepatic Encephalopathy Drug Market Competitive Situation and Trends 2.5.1 Hepatic Encephalopathy Drug Market Concentration Rate 2.5.2 Global Hepatic Encephalopathy Drug Market Share of Top 5 and Top 10 Players 2.5.3 Mergers & Acquisitions, Expansion 3 Hepatic Encephalopathy Drug Company Profiles and Sales Data 3.1 Alfa Wassermann S.p.A 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Hepatic Encephalopathy Drug Product Category, Application and Specification 3.1.3 Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin(2014-2019) 3.1.4 Main Business Overview 3.2 Cosmo Pharmaceuticals S.p.A 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Hepatic Encephalopathy Drug Product Category, Application and Specification 3.2.3 Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin(2014-2019) 3.2.4 Main Business Overview 3.3 Horizon Pharma Plc 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Hepatic Encephalopathy Drug Product Category, Application and Specification 3.3.3 Horizon Pharma Plc Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin(2014-2019) 3.3.4 Main Business Overview 3.4 KannaLife Sciences, Inc. 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Hepatic Encephalopathy Drug Product Category, Application and Specification 3.4.3 KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin(2014-2019) 3.4.4 Main Business Overview 3.5 Ocera Therapeutics, Inc. 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Hepatic Encephalopathy Drug Product Category, Application and Specification 3.5.3 Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin(2014-2019) 3.5.4 Main Business Overview 3.6 Rebiotix Inc. 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Hepatic Encephalopathy Drug Product Category, Application and Specification 3.6.3 Rebiotix Inc. Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin(2014-2019) 3.6.4 Main Business Overview 3.7 Spherium Biomed S.L. 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Hepatic Encephalopathy Drug Product Category, Application and Specification 3.7.3 Spherium Biomed S.L. Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin(2014-2019) 3.7.4 Main Business Overview 3.8 Umecrine Cognition AB 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Hepatic Encephalopathy Drug Product Category, Application and Specification 3.8.3 Umecrine Cognition AB Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin(2014-2019) 3.8.4 Main Business Overview 4 Hepatic Encephalopathy Drug Market Status and Outlook by Regions 4.1 Global Market Status and Outlook by Regions 4.1.1 Global Hepatic Encephalopathy Drug Market Size and CAGR by Regions 4.1.2 North America 4.1.3 Asia-Pacific 4.1.4 Europe 4.1.5 South America 4.1.6 Middle East and Africa 4.2 Global Hepatic Encephalopathy Drug Sales and Revenue by Regions 4.2.1 Global Hepatic Encephalopathy Drug Sales and Market Share by Regions (2014-2019) 4.2.2 Global Hepatic Encephalopathy Drug Revenue and Market Share by Regions (2014-2019) 4.2.3 Global Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin (2014-2019) 4.3 North America Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin 4.3.1 United States 4.3.2 Canada 4.3.3 Mexico 4.4 Europe Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin 4.4.1 Germany 4.4.2 UK 4.4.3 France 4.4.4 Italy 4.4.5 Russia 4.4.6 Turkey 4.5 Asia-Pacific Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin 4.5.1 China 4.5.2 Japan 4.5.3 Korea 4.5.4 Southeast Asia 4.5.4.1 Indonesia 4.5.4.2 Thailand 4.5.4.3 Malaysia 4.5.4.4 Philippines 4.5.4.5 Vietnam 4.5.5 India 4.5.6 Australia 4.6 South America Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin 4.6.1 Brazil 4.7 Middle East and Africa Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin 4.7.1 Egypt 4.7.2 GCC Countries 5 Hepatic Encephalopathy Drug Application/End Users 5.1 Hepatic Encephalopathy Drug Segment by Application 5.1.1 Clinic 5.1.2 Hospital 5.1.3 Others 5.2 Global Hepatic Encephalopathy Drug Product Segment by Application 5.2.1 Global Hepatic Encephalopathy Drug Sales by Application 5.2.2 Global Hepatic Encephalopathy Drug Sales and Market Share by Application (2014-2019) 6 Global Hepatic Encephalopathy Drug Market Forecast 6.1 Global Hepatic Encephalopathy Drug Sales, Revenue Forecast (2019-2025) 6.1.1 Global Hepatic Encephalopathy Drug Sales and Growth Rate Forecast (2019-2025) 6.1.1 Global Hepatic Encephalopathy Drug Revenue and Growth Rate Forecast (2019-2025) 6.2 Global Hepatic Encephalopathy Drug Forecast by Regions 6.2.1 North America Hepatic Encephalopathy Drug Sales and Revenue Forecast (2019-2025) 6.2.2 Europe Hepatic Encephalopathy Drug Sales and Revenue Forecast (2019-2025) 6.2.3 Asia-Pacific Hepatic Encephalopathy Drug Sales and Revenue Forecast (2019-2025) 6.2.3.1 China 6.2.3.2 Japan 6.2.3.3 Korea 6.2.3.4 Southeast Asia 6.2.3.5 India 6.2.3.6 Australia 6.2.4 South America Hepatic Encephalopathy Drug Sales and Revenue Forecast (2019-2025) 6.2.5 Middle East and Africa Hepatic Encephalopathy Drug Sales and Revenue Forecast (2019-2025) 6.2.5.1 Egypt 6.2.5.2 GCC Countries 6.3 Hepatic Encephalopathy Drug Forecast by Type 6.3.1 Global Hepatic Encephalopathy Drug Sales and Revenue Forecast by Type (2019-2025) 6.3.2 RBX-2660 Gowth Forecast 6.3.3 KLS-13019 Gowth Forecast 6.4 Hepatic Encephalopathy Drug Forecast by Application 6.4.1 Global Hepatic Encephalopathy Drug Sales Forecast by Application (2019-2025) 6.4.2 Global Hepatic Encephalopathy Drug Forecast in Clinic 6.4.3 Global Hepatic Encephalopathy Drug Forecast in Hospital 7 Hepatic Encephalopathy Drug Upstream Raw Materials 7.1 Hepatic Encephalopathy Drug Key Raw Materials 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price 7.1.3 Raw Materials Key Suppliers 7.2 Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Hepatic Encephalopathy Drug Industrial Chain Analysis 8 Marketing Strategy Analysis, Distributors 8.1 Marketing Channel 8.1.1 Direct Marketing 8.1.2 Indirect Marketing 8.1.3 Marketing Channel Development Trend 8.2 Distributors 8.3 Downstream Customers 9 Research Findings and Conclusion Appendix Methodology/Research Approach Research Programs/Design Market Size Estimation Market Breakdown and Data Triangulation Data Source Secondary Sources Primary Sources Disclaimer

List of Tables and Figures Figure Hepatic Encephalopathy Drug Product Picture Figure Global Hepatic Encephalopathy Drug Revenue (Million USD) Status and Outlook (2014-2025) Figure Global Hepatic Encephalopathy Drug Sales (K Pcs) Status and Outlook (2014-2025) Figure Product Picture of RBX-2660 Table Major Players of RBX-2660 Figure Global RBX-2660 Sales (K Pcs) and Growth Rate (%)(2014-2018) Figure Product Picture of KLS-13019 Table Major Players of KLS-13019 Figure Global KLS-13019 Sales (K Pcs) and Growth Rate (%)(2014-2019) Figure Product Picture of GR-3027 Table Major Players of GR-3027 Figure Global GR-3027 Sales (K Pcs) and Growth Rate (%)(2014-2019) Figure Product Picture of SYNB-1020 Table Major Players of SYNB-1020 Figure Global SYNB-1020 Sales (K Pcs) and Growth Rate (%)(2014-2019) Figure Product Picture of Others Table Major Players of Others Figure Global Others Sales (K Pcs) and Growth Rate (%)(2014-2019) Table Global Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type Table Global Hepatic Encephalopathy Drug Sales (K Pcs) by Type (2014-2019) Table Global Hepatic Encephalopathy Drug Sales Share (%) by Type (2014-2019) Figure Global Hepatic Encephalopathy Drug Sales Market Share (%) by Type (2014-2019) Figure Global Hepatic Encephalopathy Drug Sales Market Share (%) by Type in 2018 Table Global Hepatic Encephalopathy Drug Revenue (Million USD) by Type (2014-2019) Table Global Hepatic Encephalopathy Drug Revenue Share (%) by Type (2014-2019) Figure Global Hepatic Encephalopathy Drug Revenue Share (%) by Type (2014-2019) Figure 2018 Global Hepatic Encephalopathy Drug Revenue Market Share (%) by Type Table Global Hepatic Encephalopathy Drug Price (USD/Pcs) by Type (2014-2019) Table Global Hepatic Encephalopathy Drug Sales (K Pcs) by Company (2014-2019) Table Global Hepatic Encephalopathy Drug Sales Share (%) by Company (2014-2019) Figure Global Hepatic Encephalopathy Drug Sales Share (%) by Company in 2018 Table Global Hepatic Encephalopathy Drug Revenue (Million USD) by Company (2014-2019) Table Global Hepatic Encephalopathy Drug Revenue Share (%) by Company (2014-2019) Figure Global Hepatic Encephalopathy Drug Revenue Share (%) by Company in 2018 Table Global Market Hepatic Encephalopathy Drug Average Price (USD/Pcs) by Company (2014-2019) Table Global Hepatic Encephalopathy Drug Top Players Manufacturing Base Distribution and Sales Area Table Global Hepatic Encephalopathy Drug Top Players Product Category Figure Global Hepatic Encephalopathy Drug Market Share (%) of Top 5 Players Figure Global Hepatic Encephalopathy Drug Market Share (%) of Top 10 Players Table Alfa Wassermann S.p.A Basic Information List Table Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Product Category, Application and Specification Table Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Sales Growth Rate (2014-2019) Figure Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Sales Global Market Share (%)(2014-2019) Table Cosmo Pharmaceuticals S.p.A Basic Information List Figure Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Product Category, Application and Specification Table Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Sales Growth Rate (2014-2019) Figure Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Sales Global Market Share (%)(2014-2019) Table Horizon Pharma Plc Basic Information List Figure Horizon Pharma Plc Hepatic Encephalopathy Drug Product Category, Application and Specification Table Horizon Pharma Plc Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Horizon Pharma Plc Hepatic Encephalopathy Drug Sales Growth Rate (2014-2019) Figure Horizon Pharma Plc Hepatic Encephalopathy Drug Sales Global Market Share (%)(2014-2019) Table KannaLife Sciences, Inc. Basic Information List Figure KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Product Category, Application and Specification Table KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Sales Growth Rate (2014-2019) Figure KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Sales Global Market Share (%)(2014-2019) Table Ocera Therapeutics, Inc. Basic Information List Figure Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Product Category, Application and Specification Table Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Sales Growth Rate (2014-2019) Figure Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Sales Global Market Share (%)(2014-2019) Table Rebiotix Inc. Basic Information List Figure Rebiotix Inc. Hepatic Encephalopathy Drug Product Category, Application and Specification Table Rebiotix Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Rebiotix Inc. Hepatic Encephalopathy Drug Sales Growth Rate (2014-2019) Figure Rebiotix Inc. Hepatic Encephalopathy Drug Sales Global Market Share (%)(2014-2019) Table Spherium Biomed S.L. Basic Information List Figure Spherium Biomed S.L. Hepatic Encephalopathy Drug Product Category, Application and Specification Table Spherium Biomed S.L. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Spherium Biomed S.L. Hepatic Encephalopathy Drug Sales Growth Rate (2014-2019) Figure Spherium Biomed S.L. Hepatic Encephalopathy Drug Sales Global Market Share (%)(2014-2019) Table Umecrine Cognition AB Basic Information List Figure Umecrine Cognition AB Hepatic Encephalopathy Drug Product Category, Application and Specification Table Umecrine Cognition AB Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Umecrine Cognition AB Hepatic Encephalopathy Drug Sales Growth Rate (2014-2019) Figure Umecrine Cognition AB Hepatic Encephalopathy Drug Sales Global Market Share (%)(2014-2019) Table Global Hepatic Encephalopathy Drug Market Size Comparison by Regions (2014-2025) Figure North America Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Asia-Pacific Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Europe Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure South America Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Middle East and Africa Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (%)(2014-2025) Table Global Hepatic Encephalopathy Drug Sales (K Pcs) by Regions (2014-2019) Table Global Hepatic Encephalopathy Drug Sales Market Share (%) by Regions (2014-2019) Figure Global Hepatic Encephalopathy Drug Sales Market Share (%) by Regions (2014-2019) Figure 2018 Global Hepatic Encephalopathy Drug Sales Market Share (%) by Regions Table Global Hepatic Encephalopathy Drug Revenue (Million USD) by Regions (2014-2019) Table Global Hepatic Encephalopathy Drug Revenue Market Share (%) by Regions (2014-2019) Figure Global Hepatic Encephalopathy Drug Revenue Market Share (%) by Regions (2014-2019) Figure 2018 Global Hepatic Encephalopathy Drug Revenue Market Share (%) by Regions Table Global Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure North America Hepatic Encephalopathy Drug Sales Growth Rate Table North America Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure United States Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure United States Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Canada Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure Canada Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Mexico Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure Mexico Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Europe Hepatic Encephalopathy Drug Sales Growth Rate Table Europe Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Germany Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure Germany Hepatic Encephalopathy Drug Revenue (Million USD) (2014-2019) Figure UK Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure UK Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure France Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure France Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Italy Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure Italy Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Russia Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure Russia Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Turkey Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure Turkey Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Asia-Pacific Hepatic Encephalopathy Drug Sales Growth Rate Table Asia-Pacific Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure China Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure China Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Japan Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure Japan Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Korea Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure Korea Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Southeast Asia Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure Southeast Asia Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Indonesia Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure Indonesia Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Thailand Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure Thailand Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Malaysia Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure Malaysia Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Philippines Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure Philippines Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Vietnam Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure Vietnam Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure India Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure India Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Australia Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure Australia Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure South America Hepatic Encephalopathy Drug Sales Growth Rate Table South America Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Brazil Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure Brazil Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Middle East and Africa Hepatic Encephalopathy Drug Sales Growth Rate Table Middle East and Africa Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure North Africa Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure North Africa Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure GCC Countries Hepatic Encephalopathy Drug Sales (K Pcs)(2014-2019) Figure GCC Countries Hepatic Encephalopathy Drug Revenue (Million USD)(2014-2019) Figure Clinic Examples Figure Hospital Examples Figure Others Examples Table Global Hepatic Encephalopathy Drug Sales (K Pcs) Comparison by Application (2014-2025) Table Global Hepatic Encephalopathy Drug Sales (K Pcs) by Application (2014-2019) Table Global Hepatic Encephalopathy Drug Sales Share (%) by Application (2014-2019) Figure Global Hepatic Encephalopathy Drug Sales Market Share (%) by Application (2014-2019) Figure Global Hepatic Encephalopathy Drug Sales Market Share (%) by Application in 2018 Figure Global Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Global Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025) Table Global Hepatic Encephalopathy Drug Sales (K Pcs) Forecast by Regions (2019-2025) Figure Global Hepatic Encephalopathy Drug Sales Market Share (%) Forecast by Regions (2019-2025) Figure North America Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure North America Hepatic Encephalopathy Drug Revenue and Growth Rate (%) Forecast (2019-2025) Figure Europe Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Europe Hepatic Encephalopathy Drug Revenue and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Hepatic Encephalopathy Drug Revenue and Growth Rate (%) Forecast (2019-2025) Figure China Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure China Hepatic Encephalopathy Drug Revenue and Growth Rate (%) Forecast (2019-2025) Figure Japan Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Japan Hepatic Encephalopathy Drug Revenue and Growth Rate (%) Forecast (2019-2025) Figure Korea Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Korea Hepatic Encephalopathy Drug Revenue and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Hepatic Encephalopathy Drug Revenue and Growth Rate (%) Forecast (2019-2025) Figure India Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure India Hepatic Encephalopathy Drug Revenue and Growth Rate (%) Forecast (2019-2025) Figure Australia Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Australia Hepatic Encephalopathy Drug Revenue and Growth Rate (%) Forecast (2019-2025) Figure South America Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure South America Hepatic Encephalopathy Drug Revenue and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Hepatic Encephalopathy Drug Revenue and Growth Rate (%) Forecast (2019-2025) Figure North Africa Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure North Africa Hepatic Encephalopathy Drug Revenue and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Hepatic Encephalopathy Drug Revenue and Growth Rate (%) Forecast (2019-2025) Table Global Hepatic Encephalopathy Drug Sales (Million USD) Forecast by Type (2019-2025) Figure Global Hepatic Encephalopathy Drug Sales Market Share (%) Forecast by Type (2019-2025) Table Global Hepatic Encephalopathy Drug Revenue (Million USD) Forecast by Type (2019-2025) Figure Global Hepatic Encephalopathy Drug Revenue Market Share (%) Forecast by Type (2019-2025) Figure RBX-2660 Sales Growth Forecast Figure KLS-13019 Sales Growth Forecast Table Global Hepatic Encephalopathy Drug Sales (K Pcs) Forecast by Application (2019-2025) Figure Global Hepatic Encephalopathy Drug Sales Forecast by Application (2019-2025) Figure Global Hepatic Encephalopathy Drug Sales (K Pcs) Forecast in Clinic Figure Global Hepatic Encephalopathy Drug Sales (K Pcs) Forecast in Hospital Table Key Raw Materials Lists Figure Key Raw Materials Price Table Raw Materials Key Suppliers Lists Figure Hepatic Encephalopathy Drug Manufacturing Cost Structure Figure Hepatic Encephalopathy Drug Industrial Chain Analysis Table Distributors List Table Hepatic Encephalopathy Drug Downstream Customers

Alfa Wassermann S.p.A Cosmo Pharmaceuticals S.p.A Horizon Pharma Plc KannaLife Sciences, Inc. Ocera Therapeutics, Inc. Rebiotix Inc. Spherium Biomed S.L. Umecrine Cognition AB